Elizabeth Bortolon
- Co-authors
- Joan LevyArris J. HendersonScott M. WilhelmYong S. ChangMark LynchJalila AdnaneDean WilkiePamela A. Trail
- Topics
- Protein Degradation and Inhibitors (7 papers)Peptidase Inhibition and Analysis (4 papers)Advanced Breast Cancer Therapies (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaCancer ResearchMolecular Cancer Research
- Partner nations
- United StatesFrance
In The Last Decade
Elizabeth Bortolon
8 papers receiving 433 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 205
- Hepatology 171
- Oncology 111
- Cancer Research 104
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Elizabeth Bortolon
This map shows the geographic impact of Elizabeth Bortolon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Bortolon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Bortolon more than expected).
Fields of papers citing papers by Elizabeth Bortolon
This network shows the impact of papers produced by Elizabeth Bortolon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Bortolon. The network helps show where Elizabeth Bortolon may publish in the future.
Co-authorship network of co-authors of Elizabeth Bortolon
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Bortolon. A scholar is included among the top collaborators of Elizabeth Bortolon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Bortolon. Elizabeth Bortolon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 12 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | Analysis of transcription and protein expression changes in the 786-O human renal cell carcinoma tumor xenograft model in response to treatment with the multi-kinase inhibitor sorafenib (BAY 43-9006) | 25 |
| 9 | 388 |
About Elizabeth Bortolon
Elizabeth Bortolon is a scholar working on Hematology, Oncology and Cancer Research, having authored 9 papers that have together received 443 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (4 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Hepatology (171 citations), Cancer Research (104 citations) and Pathology and Forensic Medicine (90 citations). Elizabeth Bortolon has collaborated with scholars based in United States and France. Frequent co-authors include Joan Levy, Arris J. Henderson, Scott M. Wilhelm, Yong S. Chang, Mark Lynch, Jalila Adnane, Dean Wilkie, Pamela A. Trail, Marina Ichetovkin and Christopher A. Carter. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.